Tango Therapeutics Inc (TNGX) stock news · rev $62.4M
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
This TNGX news page leads with what Tango Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for TNGX yet. We will not pad this page with generic market recap.
Latest reported TNGX revenue for 2025-12-31 was $62.4M. Net income was -$101.6M. Revenue was up 48.3% from 2024-12-31 to 2025-12-31. TNGX currently screens at market cap $5.36B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TNGX stock page; for the tape open the quote page.
TNGX stock news FAQ
What are TNGX's latest revenue and net income?
Latest cached Tango Therapeutics Inc (TNGX) revenue for Dec 31, 2025 was $62.4M. Net income was -$101.6M. Statements: https://lician.com/financials/tngx
How did TNGX revenue change from the prior cached period?
Cached Tango Therapeutics Inc (TNGX) revenue was up 48.3% from $42.1M (Dec 31, 2024) to $62.4M (Dec 31, 2025). Statements: https://lician.com/financials/tngx
What is TNGX's market cap?
Tango Therapeutics Inc (TNGX) market cap is $5.36B on the latest cached fundamentals snapshot.
What kind of company is TNGX?
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Where is TNGX stock news listed?
Cached stock news for Tango Therapeutics Inc (TNGX) is listed at https://lician.com/news/tngx. Filings: https://lician.com/sec/tngx
Not investment advice.